Reduction in cyclin D1/Cdk4/retinoblastoma protein signaling by CRE-decoy oligonucleotide

Yun Gyu Park, Serkin Park, Seoung Ok Lim, Moon Seop Lee, Chong Kun Ryu, Insun Kim, Yoon S. Cho-Chung

Research output: Contribution to journalArticle

26 Citations (Scopus)

Abstract

We have previously demonstrated that the activation of p53 signaling may contribute to tumor growth inhibition by the CRE-decoy oligonucleotide containing CRE sequence (5′-TGACGTCA-3′) (Lee et al., Biochemistry 39, 4863-4868, 2000). However, growth inhibition by CRE-decoy treatment was also observed in tumor cells containing a mutant p53 (Park et al., J. Biol. Chem. 274, 1573-1580, 1999). To understand additional mechanisms of the decoy oligonucleotide, we investigated the effect on cyclin D1 expression and a cyclin D1/Cdk4/retinoblastoma protein (pRB) signaling pathway. Here we show that in MCF7 breast cancer cells the CRE-decoy competed with cyclin D1-CRE (5′-TAACGTCA-3′) for binding transcription factors and reduced cyclin D1 gene expression (in reporter gene assay, Northern blotting and Western blotting) to modulate cyclin D1/Cdk4/pRB signaling and G1-S progression in a steady state and/or under estrogen stimulation. Decrease of cyclin D1 protein level by CRE-decoy treatment was also observed in p53-mutated cancer cells. Cyclin D1 expression was also diminished in MCF7 cells stably expressing dominant negative mutant CREB indicating that the nonspecific effect of oligonucleotide or its degradation products could be excluded. These data suggest that inhibition of cyclin D1 expression contributes to the growth inhibition induced by the decoy oligonucleotide in MCF7 cells through a cyclin D1/Cdk4/pRB signaling pathway. Downregulation of cyclin D1 expression also provides a mechanism of CRE-decoy-induced growth inhibition in tumor cells having p53 mutation.

Original languageEnglish
Pages (from-to)1213-1219
Number of pages7
JournalBiochemical and Biophysical Research Communications
Volume281
Issue number5
DOIs
Publication statusPublished - 2001 Jan 1

Fingerprint

Cyclin-Dependent Kinase 4
Retinoblastoma Protein
Cyclin D1
Oligonucleotides
Cells
Tumors
MCF-7 Cells
Growth
Neoplasms
Transcription Factor 3
bcl-1 Genes
Biochemistry
Reporter Genes
Northern Blotting
Gene expression
Estrogens
Down-Regulation
Assays
Western Blotting
Transcription Factors

Keywords

  • CRE-decoy oligonucleotide
  • Cyclin D1
  • G1 phase arrest
  • Retinoblastoma protein
  • Tumor growth inhibition

ASJC Scopus subject areas

  • Biophysics
  • Biochemistry
  • Molecular Biology
  • Cell Biology

Cite this

Reduction in cyclin D1/Cdk4/retinoblastoma protein signaling by CRE-decoy oligonucleotide. / Park, Yun Gyu; Park, Serkin; Lim, Seoung Ok; Lee, Moon Seop; Ryu, Chong Kun; Kim, Insun; Cho-Chung, Yoon S.

In: Biochemical and Biophysical Research Communications, Vol. 281, No. 5, 01.01.2001, p. 1213-1219.

Research output: Contribution to journalArticle

Park, Yun Gyu ; Park, Serkin ; Lim, Seoung Ok ; Lee, Moon Seop ; Ryu, Chong Kun ; Kim, Insun ; Cho-Chung, Yoon S. / Reduction in cyclin D1/Cdk4/retinoblastoma protein signaling by CRE-decoy oligonucleotide. In: Biochemical and Biophysical Research Communications. 2001 ; Vol. 281, No. 5. pp. 1213-1219.
@article{c14e49c70b5142f1ae2b0ecdcff69eaa,
title = "Reduction in cyclin D1/Cdk4/retinoblastoma protein signaling by CRE-decoy oligonucleotide",
abstract = "We have previously demonstrated that the activation of p53 signaling may contribute to tumor growth inhibition by the CRE-decoy oligonucleotide containing CRE sequence (5′-TGACGTCA-3′) (Lee et al., Biochemistry 39, 4863-4868, 2000). However, growth inhibition by CRE-decoy treatment was also observed in tumor cells containing a mutant p53 (Park et al., J. Biol. Chem. 274, 1573-1580, 1999). To understand additional mechanisms of the decoy oligonucleotide, we investigated the effect on cyclin D1 expression and a cyclin D1/Cdk4/retinoblastoma protein (pRB) signaling pathway. Here we show that in MCF7 breast cancer cells the CRE-decoy competed with cyclin D1-CRE (5′-TAACGTCA-3′) for binding transcription factors and reduced cyclin D1 gene expression (in reporter gene assay, Northern blotting and Western blotting) to modulate cyclin D1/Cdk4/pRB signaling and G1-S progression in a steady state and/or under estrogen stimulation. Decrease of cyclin D1 protein level by CRE-decoy treatment was also observed in p53-mutated cancer cells. Cyclin D1 expression was also diminished in MCF7 cells stably expressing dominant negative mutant CREB indicating that the nonspecific effect of oligonucleotide or its degradation products could be excluded. These data suggest that inhibition of cyclin D1 expression contributes to the growth inhibition induced by the decoy oligonucleotide in MCF7 cells through a cyclin D1/Cdk4/pRB signaling pathway. Downregulation of cyclin D1 expression also provides a mechanism of CRE-decoy-induced growth inhibition in tumor cells having p53 mutation.",
keywords = "CRE-decoy oligonucleotide, Cyclin D1, G1 phase arrest, Retinoblastoma protein, Tumor growth inhibition",
author = "Park, {Yun Gyu} and Serkin Park and Lim, {Seoung Ok} and Lee, {Moon Seop} and Ryu, {Chong Kun} and Insun Kim and Cho-Chung, {Yoon S.}",
year = "2001",
month = "1",
day = "1",
doi = "10.1006/bbrc.2001.4521",
language = "English",
volume = "281",
pages = "1213--1219",
journal = "Biochemical and Biophysical Research Communications",
issn = "0006-291X",
publisher = "Academic Press Inc.",
number = "5",

}

TY - JOUR

T1 - Reduction in cyclin D1/Cdk4/retinoblastoma protein signaling by CRE-decoy oligonucleotide

AU - Park, Yun Gyu

AU - Park, Serkin

AU - Lim, Seoung Ok

AU - Lee, Moon Seop

AU - Ryu, Chong Kun

AU - Kim, Insun

AU - Cho-Chung, Yoon S.

PY - 2001/1/1

Y1 - 2001/1/1

N2 - We have previously demonstrated that the activation of p53 signaling may contribute to tumor growth inhibition by the CRE-decoy oligonucleotide containing CRE sequence (5′-TGACGTCA-3′) (Lee et al., Biochemistry 39, 4863-4868, 2000). However, growth inhibition by CRE-decoy treatment was also observed in tumor cells containing a mutant p53 (Park et al., J. Biol. Chem. 274, 1573-1580, 1999). To understand additional mechanisms of the decoy oligonucleotide, we investigated the effect on cyclin D1 expression and a cyclin D1/Cdk4/retinoblastoma protein (pRB) signaling pathway. Here we show that in MCF7 breast cancer cells the CRE-decoy competed with cyclin D1-CRE (5′-TAACGTCA-3′) for binding transcription factors and reduced cyclin D1 gene expression (in reporter gene assay, Northern blotting and Western blotting) to modulate cyclin D1/Cdk4/pRB signaling and G1-S progression in a steady state and/or under estrogen stimulation. Decrease of cyclin D1 protein level by CRE-decoy treatment was also observed in p53-mutated cancer cells. Cyclin D1 expression was also diminished in MCF7 cells stably expressing dominant negative mutant CREB indicating that the nonspecific effect of oligonucleotide or its degradation products could be excluded. These data suggest that inhibition of cyclin D1 expression contributes to the growth inhibition induced by the decoy oligonucleotide in MCF7 cells through a cyclin D1/Cdk4/pRB signaling pathway. Downregulation of cyclin D1 expression also provides a mechanism of CRE-decoy-induced growth inhibition in tumor cells having p53 mutation.

AB - We have previously demonstrated that the activation of p53 signaling may contribute to tumor growth inhibition by the CRE-decoy oligonucleotide containing CRE sequence (5′-TGACGTCA-3′) (Lee et al., Biochemistry 39, 4863-4868, 2000). However, growth inhibition by CRE-decoy treatment was also observed in tumor cells containing a mutant p53 (Park et al., J. Biol. Chem. 274, 1573-1580, 1999). To understand additional mechanisms of the decoy oligonucleotide, we investigated the effect on cyclin D1 expression and a cyclin D1/Cdk4/retinoblastoma protein (pRB) signaling pathway. Here we show that in MCF7 breast cancer cells the CRE-decoy competed with cyclin D1-CRE (5′-TAACGTCA-3′) for binding transcription factors and reduced cyclin D1 gene expression (in reporter gene assay, Northern blotting and Western blotting) to modulate cyclin D1/Cdk4/pRB signaling and G1-S progression in a steady state and/or under estrogen stimulation. Decrease of cyclin D1 protein level by CRE-decoy treatment was also observed in p53-mutated cancer cells. Cyclin D1 expression was also diminished in MCF7 cells stably expressing dominant negative mutant CREB indicating that the nonspecific effect of oligonucleotide or its degradation products could be excluded. These data suggest that inhibition of cyclin D1 expression contributes to the growth inhibition induced by the decoy oligonucleotide in MCF7 cells through a cyclin D1/Cdk4/pRB signaling pathway. Downregulation of cyclin D1 expression also provides a mechanism of CRE-decoy-induced growth inhibition in tumor cells having p53 mutation.

KW - CRE-decoy oligonucleotide

KW - Cyclin D1

KW - G1 phase arrest

KW - Retinoblastoma protein

KW - Tumor growth inhibition

UR - http://www.scopus.com/inward/record.url?scp=0034811055&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0034811055&partnerID=8YFLogxK

U2 - 10.1006/bbrc.2001.4521

DO - 10.1006/bbrc.2001.4521

M3 - Article

VL - 281

SP - 1213

EP - 1219

JO - Biochemical and Biophysical Research Communications

JF - Biochemical and Biophysical Research Communications

SN - 0006-291X

IS - 5

ER -